Literature DB >> 28849467

Metabolomics Profiling of the Effects of Taurine Supplementation on Dyslipidemia in a High-Fat-Diet-Induced Rat Model by 1H NMR Spectroscopy.

Kyoung Soo Kim1,2, Eunjung Bang3.   

Abstract

Metabolomics, the comprehensive study of metabolites, has merged as a potent tool for analyzing complex phenotypes and identifying biomarkers of specific physiological responses and has the potential to lead to innovative therapeutic and diagnostic schemes for many diseases. In a former report, we showed that taurine supplementation considerably ameliorated dyslipidemia in rats fed a high-caloric diet. In this work, we examined the metabolic changes that occur in rat serum after they were fed a normal diet, a high-fat diet, and a high-fat diet containing 2% taurine (tau) by NMR spectroscopy combined with a multivariate statistical analysis containing PCA, PLS-DA, and OPLS-DA. We obtained 1H-NMR spectra of rat serum and used pattern recognition to identify key metabolites related to taurine supplementation. We found significant changes in creatine, methionine, glutamine, and threonine as well as in lipids, all of which decreased in the Tau group. To use these changes in metabolites as novel therapeutic and diagnostic markers, it should first be investigated whether these results are reproducible in future experiments. Next, researchers should determine how these changes affect serum lipid changes. This study identified some changes in serum metabolites and demonstrated the possibility of using an NMR-based metabolomics method to explore the effects of a taurine supplement on dyslipidemia in a high-fat-diet-induced rat model.

Entities:  

Keywords:  Dyslipidemia; High-fat diet-induced rat model; Metabolomics; NMR spectroscopy

Mesh:

Substances:

Year:  2017        PMID: 28849467     DOI: 10.1007/978-94-024-1079-2_29

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  1 in total

1.  Neuroprotective effect and mechanism of baicalin on Parkinson's disease model induced by 6-OHDA.

Authors:  Li Tu; Zhuo-Yu Wu; Xiu-Lin Yang; Qian Zhang; Ran Gu; Qian Wang; Tian Tian; Huan Yao; Xiang Qu; Jin-Yong Tian
Journal:  Neuropsychiatr Dis Treat       Date:  2019-12-31       Impact factor: 2.570

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.